Total Payments
$6,406
2023 Payments
$3,582
Companies
3
Transactions
22
Payment Breakdown by Category
Research$3,582 (55.9%)
Consulting$2,170 (33.9%)
Food & Beverage$408.73 (6.4%)
Travel$245.24 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3,582 | 10 | 55.9% |
| Consulting Fee | $2,170 | 1 | 33.9% |
| Food and Beverage | $408.73 | 8 | 6.4% |
| Travel and Lodging | $245.24 | 3 | 3.8% |
Payments by Type
Research
$3,582
10 transactions
General
$2,824
12 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Swing Therapeutics, Inc. | $3,582 | 10 | $0 (2023) |
| Johnson & Johnson Health Care Systems Inc. | $2,656 | 10 | $0 (2017) |
| Lilly USA, LLC | $167.72 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $3,582 | 10 | Swing Therapeutics, Inc. ($3,582) |
| 2018 | $87.23 | 1 | Lilly USA, LLC ($87.23) |
| 2017 | $2,737 | 11 | Johnson & Johnson Health Care Systems Inc. ($2,656) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2023 | Swing Therapeutics, Inc. | Stanza (Device) | — | Cash or cash equivalent | $261.00 | Research |
| Study: "REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia • Category: Fibromyalgia | ||||||
| 11/03/2023 | Swing Therapeutics, Inc. | Stanza (Device) | — | Cash or cash equivalent | $252.00 | Research |
| Study: "REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia • Category: Fibromyalgia | ||||||
| 10/02/2023 | Swing Therapeutics, Inc. | Stanza (Device) | — | Cash or cash equivalent | $198.00 | Research |
| Study: "REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia • Category: Fibromyalgia | ||||||
| 09/22/2023 | Swing Therapeutics, Inc. | Stanza (Device) | — | Cash or cash equivalent | $126.00 | Research |
| Study: "REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia • Category: Fibromyalgia | ||||||
| 07/20/2023 | Swing Therapeutics, Inc. | Stanza (Device) | — | Cash or cash equivalent | $198.00 | Research |
| Study: "REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia • Category: Fibromyalgia | ||||||
| 06/20/2023 | Swing Therapeutics, Inc. | Stanza (Device) | — | Cash or cash equivalent | $180.00 | Research |
| Study: "REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia • Category: Fibromyalgia | ||||||
| 04/26/2023 | Swing Therapeutics, Inc. | Stanza (Device) | — | Cash or cash equivalent | $684.00 | Research |
| Study: "REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia • Category: Fibromyalgia | ||||||
| 03/28/2023 | Swing Therapeutics, Inc. | Stanza (Device) | — | Cash or cash equivalent | $522.00 | Research |
| Study: "REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia • Category: Fibromyalgia | ||||||
| 02/22/2023 | Swing Therapeutics, Inc. | Stanza (Device) | — | Cash or cash equivalent | $693.00 | Research |
| Study: "REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia • Category: Fibromyalgia | ||||||
| 01/23/2023 | Swing Therapeutics, Inc. | Stanza (Device) | — | Cash or cash equivalent | $468.00 | Research |
| Study: "REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia • Category: Fibromyalgia | ||||||
| 10/23/2018 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $87.23 | General |
| Category: Neuroscience | ||||||
| 12/13/2017 | Johnson & Johnson Health Care Systems Inc. | INVOKANA (Drug) | Travel and Lodging | Cash or cash equivalent | $39.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/13/2017 | Johnson & Johnson Health Care Systems Inc. | INVOKANA (Drug) | Food and Beverage | Cash or cash equivalent | $11.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/27/2017 | Johnson & Johnson Health Care Systems Inc. | INVOKANA (Drug) | Consulting Fee | Cash or cash equivalent | $2,170.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2017 | Johnson & Johnson Health Care Systems Inc. | INVOKANA (Drug) | Travel and Lodging | In-kind items and services | $181.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2017 | Johnson & Johnson Health Care Systems Inc. | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $115.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2017 | Johnson & Johnson Health Care Systems Inc. | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $49.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2017 | Johnson & Johnson Health Care Systems Inc. | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2017 | Johnson & Johnson Health Care Systems Inc. | INVOKANA (Drug) | Travel and Lodging | In-kind items and services | $24.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2017 | Johnson & Johnson Health Care Systems Inc. | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2017 | Johnson & Johnson Health Care Systems Inc. | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/27/2017 | Lilly USA, LLC | HUMALOG (Drug) | Food and Beverage | In-kind items and services | $80.49 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| "REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia | Swing Therapeutics, Inc. | $3,582 | 10 |
About Dr. Brian Keefe, MD
Dr. Brian Keefe, MD is a Forensic Psychiatry healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154397289.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Keefe, MD has received a total of $6,406 in payments from pharmaceutical and medical device companies, with $3,582 received in 2023. These payments were reported across 22 transactions from 3 companies. The most common payment nature is "" ($3,582).
Ad
Practice Information
- Specialty Forensic Psychiatry
- Other Specialties Psychiatry
- Location Boston, MA
- Active Since 02/28/2006
- Last Updated 02/14/2011
- Taxonomy Code 2084F0202X
- Entity Type Individual
- NPI Number 1154397289
Products in Payments
- Stanza (Device) $3,582
- INVOKANA (Drug) $2,656
- EMGALITY (Drug) $87.23
- HUMALOG (Drug) $80.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Forensic Psychiatry Doctors in Boston
Dr. Michael Ostacher, Md, MD
Forensic Psychiatry — Payments: $57,960
Forensic Psychiatry $57,960
Stephanie Taormina, Md, MD
Forensic Psychiatry — Payments: $372.88
Forensic Psychiatry $372.88
Dr. Susan Swick, Md, MD
Forensic Psychiatry
Forensic Psychiatry
Dr. Ronald Schouten, Md, MD
Forensic Psychiatry
Forensic Psychiatry
Dr. Donald Condie, Md, MD
Forensic Psychiatry
Forensic Psychiatry
Dr. Pamela Beasley, Md, MD
Forensic Psychiatry
Forensic Psychiatry